NASDAQ · AHCO
Healthcare · Medical - Devices
$5.85
Up+$0.15 (+2.63%)
Updated Sep 11, 2026, 4:06 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
AHCO closed at $5.85 after 20 trading sessions, up 2.63% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $5.75 | $5.91 | $5.71 | $5.85 | 3.23M |
| Sep 9, 2026 | $5.92 | $5.99 | $5.605 | $5.70 | 3.57M |
| Sep 8, 2026 | $6.48 | $6.52 | $6.105 | $6.19 | 2.89M |
| Sep 4, 2026 | $6.32 | $6.52 | $6.2425 | $6.49 | 2.61M |
| Sep 3, 2026 | $6.12 | $6.455 | $6.03 | $6.42 | 3.21M |
| Sep 2, 2026 | $5.60 | $6.14 | $5.56 | $6.04 | 3.67M |
| Sep 1, 2026 | $5.58 | $5.7041 | $5.455 | $5.51 | 2.38M |
| Aug 31, 2026 | $5.83 | $5.83 | $5.545 | $5.59 | 2.62M |
| Aug 28, 2026 | $5.80 | $5.885 | $5.77 | $5.79 | 1.76M |
| Aug 27, 2026 | $5.66 | $5.835 | $5.53 | $5.80 | 2.25M |
| Aug 26, 2026 | $5.47 | $5.685 | $5.39 | $5.67 | 2.26M |
| Aug 25, 2026 | $5.62 | $5.67 | $5.45 | $5.48 | 4.08M |
| Aug 24, 2026 | $5.63 | $5.66 | $5.555 | $5.63 | 1.74M |
| Aug 21, 2026 | $5.41 | $5.64 | $5.36 | $5.63 | 1.92M |
| Aug 20, 2026 | $5.61 | $5.695 | $5.32 | $5.39 | 2.69M |
| Aug 19, 2026 | $5.88 | $5.94 | $5.63 | $5.66 | 2.66M |
| Aug 18, 2026 | $5.80 | $5.95 | $5.72 | $5.82 | 3.16M |
| Aug 17, 2026 | $5.89 | $5.93 | $5.71 | $5.81 | 2.59M |
| Aug 14, 2026 | $5.70 | $5.905 | $5.69 | $5.81 | 2.35M |
| Aug 13, 2026 | $5.79 | $5.94 | $5.69 | $5.70 | 2.51M |
The latest Smart Investors Daily articles mentioning AHCO.
AHCO research
Company profile and research snapshot.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | UBS | Buy | — |
| Aug 6, 2026 | RBC Capital | Outperform | — |
| Aug 5, 2026 | Truist Securities | Buy | — |
| Jul 21, 2026 | Jefferies | Buy | — |
| Jul 6, 2026 | Baird | Outperform | — |
No generated briefing is available yet.
Yahoo · Sep 1, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q2.
Yahoo · Aug 17, 2026
Cathay Capital today announced the launch of ReDream Brands, a new consumer sleep health platform dedicated to helping millions of people achieve better sleep and healthier lives. The platform brings together four of the industry's most recognized direct-to-consumer brands: cpap.com, The CPAP Shop, Lofta and sleeping.com, creating a leading platform for cash-pay OSA customers across North America.
Yahoo · Aug 13, 2026
AdaptHealth’s second quarter results prompted a significant negative market reaction, as the company reported both revenue and profitability well below Wall Street’s expectations. Management attributed this to a combination of operational inefficiencies in its large West Coast capitated contract and cost pressures from a sudden supplier price increase. CEO Suzanne Foster described the unexpected operational challenges as “not sustainable,” highlighting elevated costs from higher-than-anticipated
Yahoo · Aug 7, 2026
CONSHOHOCKEN, Pa., August 07, 2026--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences:
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AHCO.
